Early Evidence Generation: A Strategic Roadmap to Successful Market Access

The Power of Early Evidence in Market Access

Demonstrating value: Real-World Evidence (RWE) in IRA’s Medicare Drug Price Negotiation

Getting real: real-world evidence in healthcare

My summer internship at Symmetron

A cloud computing solution for improving the run-time of individual patient simulation models

Unmet medical need and market access: enabler or barrier to innovation?

What is qualitative evidence synthesis?

Market access: budget impact analysis

When is a simple model enough? How to handle structural uncertainty in cost-effectiveness models.

Health economic modelling: a guide for pharmaceutical and medical device companies

Evidence generation and communication in drug development

Market access for immuno-oncology (I-O) therapies in the UK

Evidence synthesis for healthcare decision-making